- Residency - Saint Joseph Mercy Hospital-Ann Arbor, MI (2004-2005), Internal Medicine
- Graduate School - UT Southwestern Medical School (2009-2012)
- Other Post Graduate Training - UT Southwestern Medical Center (2008-2009), Dermatology
- Residency - Henry Ford Hospital (2005-2008), Dermatology
- Medical School - Johns Hopkins University (1999-2004)
- Internship - Saint Joseph Mercy Hospital-Ann Arbor, MI (2004-2005)
Benjamin Chong, M.D.
- Anita C. Gilliam, M.D., Ph.D. Professorship in Dermatology
- Dermatology - General
Benjamin Chong, M.D., is a Professor in the Department of Dermatology at UT Southwestern Medical Center and holds the Anita C. Gilliam, M.D., Ph.D., Professorship in Dermatology. He specializes in general dermatology and has expertise in cutaneous lupus erythematosus, dermatomyositis, and sarcoidosis.
Dr. Chong is Director of the UT Southwestern Connective Tissue Disease Clinic and Medical Director of the Parkland Health and Hospital System Dermatology Clinic.
He earned his undergraduate degree at Harvard University and his medical degree at Johns Hopkins University School of Medicine. He completed his internal medicine internship at St. Joseph Mercy Ann Arbor and his dermatology residency at Henry Ford Hospital, where he served as Chief Resident.
Dr. Chong conducts clinical and translational research in cutaneous lupus, an autoimmune and photosensitive skin condition in patients with systemic lupus erythematosus. He is the principal investigator of the UT Southwestern Cutaneous Lupus Registry, which contains clinical and historical data and blood and skin samples from more than 300 patients. The registry serves as a foundation for multiple clinical and translational research studies, which include developing outcome measures for clinical trials in cutaneous lupus, investigating serum biomarkers that correlate with disease progression, and deciphering the pathophysiology of cutaneous lupus erythematosus.
Dr. Chong has received research funding from the Dermatology Foundation, the American College of Rheumatology, the Arthritis Foundation, the Rheumatology Research Foundation, and the National Institutes of Health. He has authored 39 peer-reviewed journal manuscripts and four book chapters.
He is a member of several professional organizations, including the American Academy of Dermatology, the Society for Investigative Dermatology, the Rheumatologic Dermatology Society, and the Texas Medical Association.
- Lupus Foundation of America, North Texas Chapter (2012), Medical Advisory Council Member
- American College of Rheumatology (2011), Member
- Rheumatologic Dermatology Society (2010), Member/Research Committee
- Medical Dermatology Society (2009)
- American Academy of Dermatology (2008), Member
- Texas Medical Association (2008), Member
- Society of Investigative Dermatology (2008), Member
- D Magazine Best Doctor 2020-2022
- UTSW Department of Dermatology Teaching Award 2012
- Dermatology Foundation Physician-Scientist Career Development Award 2009
- Clinical Research Scholars Program 2009
- Henry Ford Hospital Outstanding Resident Award 2008, 1st prize
- La Roche-Posay North American Foundation Research Award 2006, 1st prize
- Howard Hughes Medical Institute Research Scholar 2003
The cutaneous immune system: a skin-based perspective on immunology. in Cutaneous Manifestations of Rheumatic Diseases, 2nd Ed
Chong BF, Kupper TS (2004), Philadelphia, PA, Lippincott, Williams and Wilkins
Skin disease in cutaneous lupus erythematosus. in Dubois' Lupus Erythematosus and Related Syndromes, 8th Ed
Chong BF, Werth VP. (2013), Philadelphia, PA, Elsevier Saunders
- The cutaneous immune system: a skin-based perspective on immunology. in Cutaneous Manifestations of Rheumatic Diseases, 2nd Ed
Pathogenesis of morphoea: knowledge gaps in subtypes and comparisons to systemic sclerosis.
Chong BF The British journal of dermatology 2017 Jul 177 1 9-10
Creation of an Internal Teledermatology Store-and-Forward System in an Existing Electronic Health Record: A Pilot Study in a Safety-Net Public Health and Hospital System.
Carter ZA, Goldman S, Anderson K, Li X, Hynan LS, Chong BF, Dominguez AR JAMA dermatology 2017 Apr
Predictors of low quality of life in discoid lupus patients.
Teske NM, Cardon ZE, Ogunsanya ME, Li X, Adams-Huet B, Chong B The British journal of dermatology 2017 Mar
Patient-reported outcomes in patients with cutaneous lupus.
Chong BF The British journal of dermatology 2017 Jan 176 1 7
Changes in T cell and B cell composition in discoid lupus erythematosus skin at different stages.
O'Brien JC, Hosler GA, Chong BF Journal of dermatological science 2016 Dec
Reducing outpatient dermatology clinic wait times in a safety net health system in Dallas, Texas.
O'Brien JC, Chong BF Journal of the American Academy of Dermatology 2016 Sep 75 3 631-2
Myeloid-derived Suppressor Cells in Psoriasis Are an Expanded Population Exhibiting Diverse T cell-Suppressor Mechanisms.
Cao LY, Chung JS, Teshima T, Feigenbaum L, Cruz PD, Jacobe HT, Chong BF, Ariizumi K The Journal of investigative dermatology 2016 May
Heightened Cleavage of Axl Receptor Tyrosine Kinase by ADAM metalloproteases may contribute to disease pathogenesis in SLE.
Orme JJ, Du Y, Vanarsa K, Mayeux J, Li L, Mutwally A, Arriens C, Min S, Hutcheson J, Davis LS, Chong BF, Satterthwaite AB, Wu T, Mohan C Clinical immunology (Orlando, Fla.) 2016 May
Sunscreen use in cutaneous lupus erythematosus patients.
Gutmark EL, Lin DQ, Bernstein I, Wang SQ, Chong BF The British journal of dermatology 2015 Feb
Detection of Type VII Collagen Autoantibodies Before the Onset of Bullous Systemic Lupus Erythematosus.
Grabell DA, Matthews LA, Yancey KB, Chong BF JAMA dermatology 2015 Feb
A subset of CD163(+) macrophages displays mixed polarizations in discoid lupus skin.
Chong BF, Tseng LC, Hosler GA, Teske NM, Zhang S, Karp DR, Olsen NJ, Mohan C Arthritis research & therapy 2015 17 1 324
Autoantibodies and Disease Activity in Patients With Discoid Lupus Erythematosus.
Kim A, O'Brien J, Tseng LC, Zhang S, Chong BF JAMA dermatology 2014 Apr
Differential expression of BAFF and its receptors in discoid lupus erythematosus patients.
Chong BF, Tseng LC, Kim A, Miller RT, Yancey KB, Hosler GA Journal of dermatological science 2014 Mar 73 3 216-24
Site-specific analysis of inflammatory markers in discoid lupus erythematosus skin.
Thorpe RB, Gray A, Kumar KR, Susa JS, Chong BF TheScientificWorldJournal 2014 2014 925805
Understanding How Cutaneous Lupus Erythematosus Progresses to Systemic Lupus Erythematosus.
Chong BF JAMA dermatology 2014 Jan
IgG, IgM, and IgA antinuclear antibodies in discoid and systemic lupus erythematosus patients.
Jost SA, Tseng LC, Matthews LA, Vasquez R, Zhang S, Yancey KB, Chong BF TheScientificWorldJournal 2014 2014 171028
A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral Polypodium leucotomos Extract as an Adjunct to Sunscreen in the Treatment of Melasma.
Ahmed AM, Lopez I, Perese F, Vasquez R, Hynan LS, Chong B, Pandya AG JAMA dermatology (Chicago, Ill.) 2013 Jun 1-2
Photosensitivity in cutaneous lupus erythematosus.
Kim A, Chong BF Photodermatology, photoimmunology & photomedicine 2013 Feb 29 1 4-11
Photoprotective habits of patients with cutaneous lupus erythematosus.
Yang SY, Bernstein I, Lin DQ, Chong BF Journal of the American Academy of Dermatology 2013 Jan
A multicentre, cross-sectional study on quality of life in patients with cutaneous lupus erythematosus.
Vasquez R, Wang D, Tran QP, Adams-Huet B, Chren MM, Costner MI, Cohen JB, Werth VP, Chong BF The British journal of dermatology 2013 Jan 168 1 145-53
IgG and IgM autoantibody differences in discoid and systemic lupus patients.
Chong BF, Tseng LC, Lee T, Vasquez R, Li QZ, Zhang S, Karp DR, Olsen NJ, Mohan C The Journal of investigative dermatology 2012 Dec 132 12 2770-9
Autoantibody and clinical profiles in patients with discoid lupus and borderline systemic lupus.
Vasquez R, Tseng LC, Victor S, Zhang S, Chong BF Archives of dermatology 2012 May 148 5 651-5
25-Hydroxyvitamin D levels in African-American and Caucasian/Hispanic subjects with cutaneous lupus erythematosus.
Word AP, Perese F, Tseng LC, Adams-Huet B, Olsen NJ, Chong BF The British journal of dermatology 2012 Feb 166 2 372-9
Determining risk factors for developing systemic lupus erythematosus in patients with discoid lupus erythematosus.
Chong BF, Song J, Olsen NJ The British journal of dermatology 2012 Jan 166 1 29-35
25-Hydroxyvitamin D levels in African-American and Caucasian/Hispanic subjects with cutaneous lupus erythematosus
Word AP, Perese F, Tseng LC, Adams-Huet B, Olsen NJ, Chong BF British Journal of Dermatology 2012 166 2 372-379
Risk factors for ANA positivity in healthy persons.
Li QZ, Karp DR, Quan J, Branch VK, Zhou J, Lian Y, Chong BF, Wakeland EK, Olsen NJ Arthritis research & therapy 2011 Mar 13 2 R38
Induced Sezary syndrome PBMCs poorly express immune response genes up-regulated in stimulated memory T cells.
Chong BF, Dantzer P, Germeroth T, Hafner M, Wilson AJ, Xiao G, Wong HK Journal of dermatological science 2010 Oct 60 1 8-20
Dysregulated expression of CXCR4/CXCL12 in subsets of patients with systemic lupus erythematosus
Wang A*, Guilpain P*, Chong BF*, Chouzenoux S, Guillevin L, Du Y, Zhou XJ, Lin F, Fairhurst A, Boudreaux C, Roux C, Wakeland EK, Davis L, Batteux F, Mohan C (* - co-first-authors) Arthritis & Rheumatism 2010 62 3436-3446
Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus
Chong, BF, Mohan C Expert Opin Ther Targets October 2009 13(10) 1147-53
Treatment of psoriasis with etanercept in patient with history of primary B-cell lymphoma
Chong, BF, Wong, HK Clin Exp Dermatol July 2009 34(5) e11-3
Immune function abnormalities in peripheral blood mononuclear cell cytokine expression differentiates stages of cutaneous T-cell lymphoma/mycosis fungoides
Chong BF, Wilson AJ, Gibson HM, Hafner MS, Luo Y, Hedgcock C, Wong HK Clin Cancer Res February 2008 14(3) 646-53
Concomitant morphea and pigmented purpuric dermatosis in a 62-year-old woman
Chong B, Nydorf ED, Lim HW J Eur Acad Dermatol Venereol July 2007 21(6) 826-28
Immunobiologics in the treatment of psoriasis
Chong BF, Wong HK Clin Immunol May 2007 123 129-138
A novel method for the isolation of skin resident T cells from normal and diseased human skin.
Clark RA, Chong BF, Mirchandani N, Yamanaka KI, Murphy GF, Dowgiert RK, Kupper TS. J Invest Dermatol May 2006 126 1059-1070
The vast majority of CLA+ T cells are resident in normal skin.
Clark RA, Chong B, Mirchandani N, Brinster NK, Yamanaka KI, Dowgiert RK, Kupper TS. J Immunol April 2006 176 4431-4439
E-selectin, TARC/CCL17, and ICAM-1 are constitutively co-expressed in dermal microvessels: a foundation for a cutaneous immunosurveillance system.
Chong BF, Murphy J, Kupper TS, Fuhlbrigge RC. J Immunol February 2004 172 1575-1581
- Pathogenesis of morphoea: knowledge gaps in subtypes and comparisons to systemic sclerosis.
- Cutaneous Lupus Erythematosus